Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.

Author: AlfieriS, BergaminiC, BossiP, CavalieriS, GalbiatiD, GranataR, LicitraL, LocatiL D, ResteghiniC

Paper Details 
Original Abstract of the Article :
Four tyrosine kinase inhibitors (TKIs) have been recently licensed in thyroid cancer (TC), sorafenib and lenvatinib for differentiated TC, vandetanib and cabozantinib for medullary TC. Others TKIs such as axitinib, pazopanib, sunitinib, have been tested within phase II trials. The toxicity burden as...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.beem.2017.04.012

データ提供:米国国立医学図書館(NLM)

Managing the Side Effects of Tyrosine Kinase Inhibitors in Thyroid Cancer

Tyrosine kinase inhibitors (TKIs) are powerful drugs used to treat thyroid cancer, but they can come with side effects. This study focuses on the management of these side effects in patients receiving TKIs for differentiated and medullary thyroid cancer. The researchers discuss the different TKIs used in thyroid cancer and highlight the importance of proactive prevention and management of side effects. They emphasize the need for education and communication between doctors and patients to ensure safe and effective treatment.

TKIs: Harnessing Power with Careful Management

The study emphasizes that while TKIs have shown promise in treating thyroid cancer, they can have significant side effects. The researchers highlight the importance of recognizing and managing these side effects early on to minimize their impact on patients. They advocate for proactive prevention strategies, including careful monitoring and dose adjustments, to ensure the long-term safety and effectiveness of TKI treatment.

Navigating the Terrain of Thyroid Cancer Treatment

This study highlights the complexities of treating thyroid cancer and the importance of a multidisciplinary approach. It emphasizes the need for open communication between doctors and patients to manage the potential side effects of TKIs. Just as a camel needs to be vigilant in navigating the desert, patients need to be proactive in managing their health and working closely with their doctors.

Dr. Camel's Conclusion

This study reminds us that even in the world of modern medicine, there are always challenges to overcome. The research underscores the importance of careful management of side effects to maximize the benefits of TKI treatment for thyroid cancer. The study is a reminder that the desert of medicine is vast and requires a collaborative approach between doctors and patients to navigate its complexities.

Date :
  1. Date Completed 2018-03-09
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

28911730

DOI: Digital Object Identifier

10.1016/j.beem.2017.04.012

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.